E. Neil Schachter, MD
- PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine
- PROFESSOR | Environmental Medicine & Public Health
- PROFESSOR | Pediatrics
Specialties:
Pulmonary Medicine (Lung), Sleep Medicine
A new, less invasive treatment may be on the horizon to help people suffering from chronic obstructive pulmonary disease (COPD). Featured in Inside Mount Sinai, Neil Schachter, MD, Medical Director of the Respiratory Care Department and the Maurice Hexter Professor of Pulmonary Medicine and Timothy Harkin, MD, Associate Professor of Medicine and Director of Bronchoscopy, (Pulmonary, Critical Care, and Sleep Medicine) are examining the potential therapeutic benefits of the Intra-bronchial valve system to improve the condition of patients with lung disorders.
In The News
Dr. Schachter discusses chronic obstructive pulmonary disease in The Daily News feature The Daily Check Up. View the PDF and the dangers of vaping in Vaping: The Truth About This Deadly Addition in Our Town.
Clinical Focus
- Aspergillosis
- Asthma
- Bronchitis
- Chronic Obstructive Pulmonary Disease (COPD)
- Cough
- Emphysema
- Hyperbaric Oxygen Therapy (HBOT)
- Idiopathic Pulmonary Fibrosis
- Lung Cancer
- Mesothelioma
- Pleural Mesothelioma
- Pneumococcal Vaccine
- Pneumonia
- Pulmonary Function Tests
- Pulmonary Hypertension
- Sarcoidosis
- Thoracentesis
Education
MD, New York University School of Medicine
Residency, Internal Medicine, Bellevue Hospital Center
Residency, Internal Medicine, Bellevue Hospital Center
Fellowship, Pulmonary Disease, Yale School Of Medicine
-
2006
Keynote Speaker -
2005
Honoree -
1990
Associate Editor -
1988
Professorship -
1981
Fellow -
1977
Fellow -
1974
Edward, Livingston Trudeau Fellow -
1973
Fellow
Environmental and occupational airway disease
Both clinical and in vitro studies are under way to investigate the clinical course, epideniology and mechanisms underlying airway diseases (asthma and bronchitis-like syndromes) that are seen in workers in a number of different industries. These industries employ organic compounds such as latex paper, wool, cotton, food products, and industrial wastes.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Schachter during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- American Lung Association of the Northeast
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.